drugset / Trial / NCT00429169

Paroxetine/Bupropion in Suicide Attempters/Ideators With Major Depression

NCT00429169

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The primary study comparing effectiveness for suicidal ideation and/or behavior of two antidepressant medications in depressed patients who have attempted suicide or are currently experiencing suicidal thoughts has been completed. A secondary study component using functional magnetic resonance imaging (fMRI) to investigate different medication effects on reward processing in the same sample is ongoing.

Timeline

Start
2004-06
Primary completion
2010-01
Completion
2013-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bupropion Small molecule 450 mg
Comparator Paroxetine Small molecule 50 mg